<p><strong>RH</strong> (NYSE: RH) 周四报告了超出预期的第一季度财务业绩，并上调了 2026 财年的销售指引。</p>
<p>RH 报告季度每股亏损 $1.97，超出分析师共识预期的每股亏损 $2.11。公司报告季度销售额为 $8.00328 亿，超出分析师共识预期的 $7.92780 亿。</p>
<p>RH 将其 2026 财年的销售指引从 $35.77 亿-$37.15 亿上调至 $35.94 亿-$37.15 亿。</p>
<p>RH 股价周五下跌 5.8%，交易价格为 $149.95。</p>
<p>这些分析师在财报发布后对 RH 的目标价进行了调整。</p>
<ul>
<li>Baird 分析师 Peter Benedict 维持 RH 的中性评级，并将目标价从 $125 上调至 $150。</li>
<li>Wells Fargo 分析师 Zachary Fadem 维持该股的超配评级，并将目标价从 $160 上调至 $175。</li>
<li>Stifel 分析师 W. Andrew Carter 维持 RH 的持有评级，并将目标价从 $110 上调至 $130。</li>
</ul>
<p><strong>考虑购买 RH 股票吗？以下是分析师的看法：</strong></p>
<p><img src="https://imageproxy.pbkrs.com/https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/12123658/image-340-1024x461.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/12123658/image-340-1024x461.png"/></p>
<p><em>图片来源于 Shutterstock</em></p>

<p>RH 公布的第一季度财报超出预期，并上调了 2026 财年的销售指引，但股价下跌了 5.8%。尽管股价下跌，分析师 Baird、Wells Fargo 和 Stifel 维持了各自的评级（中性、增持、持有），同时将目标价分别上调至 150 美元、175 美元和 130 美元</p>

<p><strong>RH</strong> (NYSE: RH) reported better-than-expected first-quarter financial results and raised its FY2026 sales guidance on Thursday.</p>
<div class="lb-trans"><p><strong>RH</strong> (NYSE: RH) 周四报告了超出预期的第一季度财务业绩，并上调了 2026 财年的销售指引。</p>
</div><p>RH reported quarterly losses of $1.97 per share, which beat the analyst consensus estimate of losses of $2.11 per share. The company reported quarterly sales of $800.328 million, which beat the analyst consensus estimate of $792.780 million.</p>
<div class="lb-trans"><p>RH 报告季度每股亏损 $1.97，超出分析师共识预期的每股亏损 $2.11。公司报告季度销售额为 $8.00328 亿，超出分析师共识预期的 $7.92780 亿。</p>
</div><p>RH raised its FY2026 sales guidance from $3.577 billion-$3.715 billion to $3.594 billion-$3.715 billion.</p>
<div class="lb-trans"><p>RH 将其 2026 财年的销售指引从 $35.77 亿-$37.15 亿上调至 $35.94 亿-$37.15 亿。</p>
</div><p>RH shares fell 5.8% to trade at $149.95 on Friday.</p>
<div class="lb-trans"><p>RH 股价周五下跌 5.8%，交易价格为 $149.95。</p>
</div><p>These analysts made changes to their price targets on RH following earnings announcement.</p>
<div class="lb-trans"><p>这些分析师在财报发布后对 RH 的目标价进行了调整。</p>
</div><ul>
<li>Baird analyst Peter Benedict maintained RH with a Neutral and raised the price target from $125 to $150.</li>
<li>Wells Fargo analyst Zachary Fadem maintained the stock with an Overweight rating and raised the price target from $160 to $175.</li>
<li>Stifel analyst W. Andrew Carter maintained RH with a Hold and raised the price target from $110 to $130.</li>
</ul>
<div class="lb-trans"><ul>
<li>Baird 分析师 Peter Benedict 维持 RH 的中性评级，并将目标价从 $125 上调至 $150。</li>
<li>Wells Fargo 分析师 Zachary Fadem 维持该股的超配评级，并将目标价从 $160 上调至 $175。</li>
<li>Stifel 分析师 W. Andrew Carter 维持 RH 的持有评级，并将目标价从 $110 上调至 $130。</li>
</ul>
</div><p><strong>Considering buying RH stock? Here’s what analysts think:</strong></p>
<div class="lb-trans"><p><strong>考虑购买 RH 股票吗？以下是分析师的看法：</strong></p>
</div><p><img src="https://imageproxy.pbkrs.com/https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/12123658/image-340-1024x461.png" alt="" original-src="https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/12123658/image-340-1024x461.png"/></p>
<p><em>Photo via Shutterstock</em></p>
<div class="lb-trans"><p><em>图片来源于 Shutterstock</em></p>
</div>

These Analysts Increase Their Forecasts On RH Following Better-Than-Expected Q1 Earnings

benzinga_article

富国银行

Stifel Financial

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

STIFEL FINANCIAL CORP 6.125% DEP SHS REP 1/1000 NON CU PF SR C

Stifel Financial Pref Share SFB 5.2 10/15/47

STIFEL FINANCIAL CORP 6.25%NON CUM DEP SHS REP 1/1000TH SER B

STIFEL FINANCIAL CORP 4.50% DEP SHS REP 1/1000TH PREF SHS SR D

在 RH 第一季度收益好于预期后，这些分析师提高了他们的预测